Representatives from the Food and Drug Administration will address the role of the investigational new drug (IND) in clinical research; they will provide a Radioactive Drug Research Committee update on June 5 and present updates on PET regulations on June 7. Additionally, representatives from the Nuclear Regulatory Commission will address "Running an NRC-Compliant Radiation Safety Program" on June 5. SNM members will take to Capitol Hill on June 5 to visit hometown representatives and talk about public policy issues.

On June 2, 12 categorical seminars, developed by members of SNM's various councils and centers of excellence, will be presented. These seminars will cover new directions in molecular imaging of the brain and heart, qualitative SPECT for molecular imaging, emerging clinical applications of SPECT/CT, radiopeptide imaging and therapy, molecular imaging and cancer therapy, pediatric radiotherapy, hot topics in PET/CT, multimodality molecular imaging, an assessment of nuclear cardiology, a PET/CT update in oncology and cardiology, and current issues and advances in nuclear medicine.


To register for the meeting, visit the SNM Web site at www.snm.org/am.

About SNM-Advancing Molecular Imaging and Therapy
SNM is holding its 54th Annual Meeting June 2-6 at the Washington, D.C., Convention Center. Session topics for the 2007 meeting include brain amyloid imaging, hybrid imaging, molecular imaging in clinical drug development and evaluation, functional brain imaging in epilepsy and dementia, imaging instrumentation, infection imaging, lymphoma and thyroid cancer, cardiac molecular imaging, general nuclear medicine, critical elements of care in radiopharmacy and more.

SNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed journal in the field (the Journal of Nuclear Medicine); host the premier annual meeting for medical imaging; sponsor research grants, fellowships and awards; and train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances. SNM members have introduced-and continue to explore-biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at http://www.snm.org.

Back to HCB News

More Industry Headlines